Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects

Hong, CR; Dickson, BD; Jaiswal, JK; Pruijn, FB; Hunter, FW; Hay, MP; Hicks, KO; Wilson, WR

Wilson, WR (reprint author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland, New Zealand.

BIOCHEMICAL PHARMACOLOGY, 2018; 156 (): 265

Abstract

Evofosfamide (TH-302) is a clinical-stage hypoxia-activated prodrug with proven efficacy against hypoxic cells in preclinical tumour models. TH-302 is......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索